Imbrium Therapeutics - Crunchbase Company Profile & Funding

Overview

Imbrium Therapeutics

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Imbrium Therapeutics

CB Rank

427786

Imbrium Therapeutics is a biopharma company that specializes in medical science, pharmacologic medicines, and oncology chemotherapeutics.

Founded

obfuscation

Private

Stamford, Connecticut, United States

11-50

www.imbriumthera.com/

Biotechnology

Clinical Trials

Medical

Oncology

Pharmaceutical

Therapeutics

Details

Legal Name

Imbrium Therapeutics L.P

Operating Status

Active

Company Type

For Profit

Phone Number

+1-888-827-0622

Contact Email

contactus@imbriumthera.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Tinostamustine

An investigational drug combining bifunctional alkylating activity and pan histone deacetylase inhibition, under study for glioblastoma treatment.

Sunobinop

An investigational oral compound activating nociceptin/orphanin-FQ peptide receptors, studied for alcohol use disorder, overactive bladder, and interstitial cystitis.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Contacts

News

News and Press

News•

Sep 10, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Aug 4, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Jun 16, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Nov 18, 2024

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Access a complete feed of recent news and press, from product launches to leadership changes.

Technology

View Tech Report

Monthly Web Visits

980

IT Spend

$166.1K

This year,

Imbrium Therapeutics

is projected to spend

$166.1K

on IT, according to Aberdeen.

Active Website Tech Count

Imbrium Therapeutics

is actively using

technologies for its website, according to BuiltWith. These include

reCAPTCHA

CommonCrawl Top 5m

, and

reCAPTCHA v2

Lists Featuring This Company

Pharmaceutical Companies With Less Than $1B in Revenue (Top 10K)

9,713 Number of Organizations • $304.2B Total Funding Amount • 15,588 Number of Investors

Connecticut Companies With Less Than $500M in Revenue (Top 10K)

9,708 Number of Organizations • $41.7B Total Funding Amount • 1,988 Number of Investors

United States Pharmaceutical Companies (Top 10K)

9,811 Number of Organizations • $473.4B Total Funding Amount • 9,826 Number of Investors

East Coast Therapeutics Companies

9,956 Number of Organizations • $137.5B Total Funding Amount • 5,331 Number of Investors

Sub-Organizations

Frequently Asked Questions

Where is

Imbrium Therapeutics

's headquarters?

Imbrium Therapeutics

is located in

Stamford, Connecticut, United States

Who are

Imbrium Therapeutics

's competitors? Alternatives and possible competitors to

Imbrium Therapeutics

may include

Allarity Therapeutics

Tris Pharma

, and

Agios Pharmaceuticals